registering my concern that someday we will find that NMDA inhibitors do something bad to cognition. but all these recent studies are 6-week only and don't report any side effects that look like cognitive impairment, but maybe wouldn't have been able to pick it up even if it existed.
"Azapirones (example: BuSpar) is, unusually, a rare drug which is specifically targeted at anxiety, rather than a being a repurposed antidepressant or something. BuSpar is very safe, not at all addictive, and rarely works. Every so often somebody comes out with a very cheerful study saying something like “Buspar just as effective as benzodiazepines if given correctly!” and everybody laughs hysterically and goes back to never thinking about it."
gabapentin for anxiety -- meh, some positive results but they're not extraordinary.
Gena Gorlin hosts a discussion on "psychological safety"
Good point in comments, that different people see different (sometimes opposite) things necessary for psychological safety. For some, it means they can speak candidly about whatever they think and feel. For others, it means that some things cannot be said in their presence.
I think, you can make it both, as long as it is one-sided, e.g. in a therapy, where the client could say anything, and the therapist would be careful about their feedback.
But this wouldn't work at a workplace or any other larger gro... (read more)